MetrioPharm AG
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| MP1032 Treatment in Patients With Moderate to Severe COVID-19 (NCT04932941) | MetrioPharm AG | 2021-10-19 |
| Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis (NCT03706209) | MetrioPharm AG | 2018-02-27 |
Track MetrioPharm AG automatically
Every clearance here is in the API, with alerts when new ones post.